TREATMENT AND/OR PREVENTION OF DISEASE OR SYNDROME ASSOCIATED WITH VIRAL INFECTION Russian patent published in 2024 - IPC A61K38/57 A61P31/12 

Abstract RU 2823437 C2

FIELD: pharmaceutics; medicine.

SUBSTANCE: invention relates to the use of a composition for treating and/or preventing a disease or syndrome associated with a viral infection in a subject in need thereof, where viral infection causes acute inflammation, directly or indirectly inducing disease or syndrome, and where the viral infection is a coronavirus infection MERS-CoV, wherein the composition comprises a therapeutically effective amount of alpha-1-antitrypsin (AAT) protein.

EFFECT: inhibition of penetration of MERS-CoV into cells.

8 cl, 26 dwg, 11 tbl, 25 ex

Similar patents RU2823437C2

Title Year Author Number
BISPECIFIC MONOCLONAL ANTIBODY AGAINST SARS-COV-2 2022
  • Malogolovkin Aleksandr Sergeevich
  • Katorkin Sergej Aleksandrovich
  • Bondar Nikolaj Igorevich
RU2791749C1
METHODS FOR TREATING INFECTIOUS DISEASES CAUSED BY CORONAVIRUS 2021
  • Tov, Navekh
  • Alagem, Noga
RU2772701C1
THERAPEUTIC AGENT AGAINST CORONAVIRUS INCLUDING AN ELAEOCARPUS SYLVESTRIS EXTRACT 2021
  • Kang, Se Chan
  • Jeong, Yong Joon
  • Jeon, Hye Lin
  • Her, Yang Mi
RU2780346C1
METHOD FOR DETERMINING THE ACTIVITY OF NEUTRALISING ANTIBODIES AGAINST SARS-CoV-2 IN THE SERUM OR PLASMA OF PEOPLE WITH PAST CASES OF COVID-19 OR VACCINATED WITH PREVENTIVE VACCINES AGAINST THE NOVEL CORONAVIRUS INFECTION COVID-19 USING A SET OF ENZYME IMMUNOASSAY REAGENTS CONTAINING A RECOMBINANT RECEPTOR-BINDING DOMAIN (RBD) OF SURFACE GLYCOPROTEIN S OF CORONAVIRUS SARS-CoV-2 AND RECOMBINANT HUMAN RECEPTOR ACE2 2021
  • Kostin Nikita Nikolaevich
  • Bobik Tatyana Vladimirovna
  • Skryabin Georgij Andreevich
  • Simonova Mariya Aleksandrovna
  • Balmasova Irina Petrovna
  • Abrikosova Viktoriya Aleksandrovna
  • Mokrushina Yuliana Anatolevna
  • Smirnov Ivan Vitalevich
  • Aleshenko Natalya Leonidovna
  • Nikitin Aleksej Eduardovich
  • Chekhonin Vladimir Pavlovich
  • Gabibov Aleksandr Gabibovich
RU2784655C1
5-[4-(1,3-BENZOTHIAZOL-2-YL)PHENYL]-10,15,20-TRIS(1-METHYLPYRIDINIUM-3-YL)PORPHYRIN TRIIOODIDE, SHOWING THE BINDING PROPERTY OF THE SARS-CoV-2 VIRUS SPIKE PROTEIN 2021
  • Syrbu Sergej Aleksandrovich
  • Kiselev Aleksej Nikolaevich
  • Gubarev Yurij Aleksandrovich
  • Lebedeva Natalya Shamilevna
  • Semejkin Aleksandr Stanislavovich
  • Kojfman Oskar Iosifovich
RU2773397C1
PHARMACEUTICAL COMPOSITION CONTAINING POLYNUCLEOTIDES, AND USE THEREOF FOR PREVENTING OR TREATING COVID-19 2021
  • Zhang, Yi
  • Liu, Yuan
  • Zhang, Nan
RU2824489C1
METHOD FOR THE TREATMENT OF CORONAVIRUS INFECTION CAUSED BY SARS-CoV-2 2021
  • Ivanov Evgenii Ignatevich
  • Monakhov Maksim Viacheslavovich
RU2775966C1
METHOD FOR CREATING RECOMBINANT ENTEROCOCCUS L3-SARSN1 STRAIN BASED ON BIOLOGICALLY ACTIVE ENTEROCOCCUS FAECIUM L3 STRAIN 2022
  • Suvorov Aleksandr Nikolaevich
  • Gupalova Tatyana Vitalievna
  • Leonteva Galina Fedorovna
  • Bormotova Elena Alekseevna
  • Kramskaya Tatyana Anatolevna
  • Desheva Yuliya Andreevna
RU2820058C1
COMPOSITIONS AND METHODS FOR TREATING SEVERE ACUTE RESPIRATORY SYNDROME (SARS) 2004
  • Sajber Dzhordzh R.
RU2411042C2
POLYPEPTIDE MODULE FOR BINDING CONSERVATIVE EPITOPE OF RECEPTOR-BINDING DOMAIN OF SPIKE PROTEIN OF SARS-CoV-2 CORONAVIRUS 2022
  • Tillib Sergej Vladimirovich
  • Vorobev Pavel Olegovich
RU2809183C1

RU 2 823 437 C2

Authors

Zhukovsky Nikolay

Dates

2024-07-23Published

2021-05-03Filed